KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (2017 - 2025)

Historic Interest Coverage Ratio for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to 72.12.

  • Regeneron Pharmaceuticals' Interest Coverage Ratio fell 2352.14% to 72.12 in Q4 2025 from the same period last year, while for Dec 2025 it was 81.69, marking a year-over-year increase of 1299.11%. This contributed to the annual value of 81.69 for FY2025, which is 1299.11% up from last year.
  • According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Interest Coverage Ratio is 72.12, which was down 2352.14% from 53.2 recorded in Q3 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Interest Coverage Ratio peaked at 299.86 during Q2 2025, and registered a low of 46.67 during Q1 2024.
  • Its 5-year average for Interest Coverage Ratio is 98.15, with a median of 74.24 in 2021.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Interest Coverage Ratio tumbled by 6479.51% in 2022 and then soared by 31491.63% in 2025.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Interest Coverage Ratio stood at 187.21 in 2021, then crashed by 64.8% to 65.91 in 2022, then decreased by 19.34% to 53.16 in 2023, then surged by 77.38% to 94.3 in 2024, then decreased by 23.52% to 72.12 in 2025.
  • Its last three reported values are 72.12 in Q4 2025, 53.2 for Q3 2025, and 299.86 during Q2 2025.